Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Basel | OTHER |
| University Psychiatric Clinics Basel | NETWORK |
Not provided
Not provided
Not provided
Not provided
The aim of the study is to characterize the effects of low doses of LSD (d-lysergic acid diethylamide) on behavioral and neural indicators of feedback and feedforward signaling in perceptual decision-making.
The study team will subject healthy participants to multiple perceptual decision-making tasks after the administration of low doses of LSD (d-lysergic acid diethylamide) as a pharmacological challenge. The investigators want to illuminate the behavioral and neural effects of psychedelics on prior beliefs and evidence processing. Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Subjects will be under continuous supervision until approximately 4.5h after substance administration. The participants are asked to perform the following cognitive tasks alongside EEG measurement after administration of either LSD or placebo: Changepoint task, history bias task, surround suppression task, auditory steady-state response paradigm, motor localizer task.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention order: 10 μg LSD - 20 μg LSD - Placebo | Experimental | Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be 10 μg LSD - 20 μg LSD - Placebo. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: active+placebo; 2. visit: active+active, 3. visit: placebo+placebo. |
|
| Intervention order: 10 μg LSD - Placebo - 20 μg LSD | Experimental | Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be 10 μg LSD - Placebo - 20 μg LSD. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: active+placebo; 2. visit: placebo+placebo, 3. visit: active+active. |
|
| Intervention order: 20 μg LSD - 10 μg LSD - Placebo | Experimental | Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be 20 μg LSD - 10 μg LSD - Placebo. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: active+active; 2. visit: active+placebo, 3. visit: placebo+placebo. |
|
| Intervention order: 20 μg LSD - placebo - 10 μg LSD |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| LSD 10 μg | Drug | 0.5 h after the start of each study session the participants will be administered 10 μg LSD per os in the form of vials containing 1ml 20% EtOH (ethanol). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in changepoint task | Using the changepoint task, it is examined how explicit expectations about upcoming stimuli are derived from the perceptual history and how they influence the perceptual decision in a volatile environment. The study team utilizes an established computerized task and analysis pipeline including a behavioral modeling strategy based on Bayesian inference. The task requires participants to view a train of stimuli consisting of checkerboards presented on a half-circle gradient either more on the right or more on the left side of a fixation cross. Each checkerboard represents information about whether stimuli are currently more likely to appear on the right or left side of the screen. The participants have to indicate by button press, whether they believe the right or the left side is active. Task difficulty is fixed. | three times (once on each of the three test days; interval between test days at least 7 days) |
| Change in history bias task | With the history bias task, the study team investigates how implicit expectations about upcoming stimuli are derived from perceptual history and how they bias perceptual discrimination. In each trial, two circular gratings will be presented concurrently on the left and right sides of a fixation cross. After complete stimulus presentation, the participants indicate by button press which of the two gratings they believe had the stronger contrast in the trial (left vs. right). Task difficulty will be adjusted individually using an online quest staircase procedure, such that participants will always perform at their 75% accuracy level. | three times (once on each of the three test days; interval between test days at least 7 days) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Philipp Sterzer, Prof. Dr. | University Psychiatric Clinics Basel | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Psychiatric Clinics Basel | Basel | 4002 | Switzerland |
Not provided
| ID | Term |
|---|---|
| D008238 | Lysergic Acid Diethylamide |
| ID | Term |
|---|---|
| D008237 | Lysergic Acid |
| D004873 | Ergolines |
| D004876 | Ergot Alkaloids |
| D000470 | Alkaloids |
Not provided
Not provided
Randomized, double-blinded, cross-over study
Not provided
Not provided
double-blinded
Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be 20 μg LSD -placebo - 10 μg LSD. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: active+active; 2. visit: placebo+placebo, 3. visit: active+placebo. |
|
| Intervention order: placebo - 10 μg LSD - 20 μg LSD | Experimental | Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be placebo - 10 μg LSD - 20 μg LSD. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: placebo+placebo; 2. visit: active+placebo, 3. visit: active+active. |
|
| Intervention order: placebo - 20 μg LSD - 10 μg LSD | Experimental | Each subject will participate in 3 x 5 h study sessions separated by at least 7 days. Order of drug administration will be placebo - 20 μg LSD - 10 μg LSD. Vials will contain either 10μg (Active) or 0 μg LSD (Placebo). Thus, participants will be administered two vials on each study visit. 1. visit: placebo+placebo; 2. visit: active+active, 3. visit: active+placebo. |
|
| LSD 20 μg | Drug | 0.5 h after the start of each study session the participants will be administered 20 μg LSD per os in the form of vials containing 1ml 20% EtOH. |
|
| Placebo | Drug | 0.5 h after the start of each study session the participants will be administered placebo per os in the form of vials containing 1ml 20% EtOH. |
|
| D006571 |
| Heterocyclic Compounds |
| D006576 | Heterocyclic Compounds, 4 or More Rings |
| D000072471 | Heterocyclic Compounds, Fused-Ring |